文献速递慢性肾脏病

肾小球滤过率:何时测量及适用于哪些患者

Glomerular filtration rate: when to measure and in which patients?
PubMed 文献 · Nephrol Dial Transplant · 2019-01-01

本文讨论在慢性肾脏病(CKD)管理中测量肾小球滤过率(mGFR)的临床价值。作者指出,在估算GFR不精确的情况(如肌少症、晚期肝硬化)下,mGFR对个体化治疗尤为重要;尽管人群层面未必能显示mGFR获益,但精准医学要求基于最佳GFR估计进行个体化治疗,尤其当风险增加时。

要点

  • mGFR是肾小球功能最精确的测量指标,可用于CKD患者的个体化治疗。
  • 在肌少症、晚期肝硬化等eGFR不精确的情况下,测量GFR可能尤为重要。
  • 精准医学要求基于最佳GFR估计进行个体化治疗,尤其当治疗风险增加时。

核心结论

  • mGFR在特定临床情境下可影响治疗质量或并发症,精准医学要求基于最佳GFR估计进行个体化治疗。

研究设计与样本

  • 本文为综述,讨论mGFR的临床应用时机与适用患者人群。

主要发现

  • mGFR是肾小球功能最精确的测量指标,可帮助CKD患者个体化治疗。
  • 在肌少症和晚期肝硬化等eGFR不精确的情况下,测量GFR可能尤其重要。
  • 大型数据库可能在人群层面无法检测到mGFR的获益。

临床怎么用

  • 在eGFR不精确的临床情境(如肌少症、晚期肝硬化)下,可考虑测量GFR以指导个体化治疗。
  • 当基于不完美GFR知识进行干预可能增加治疗风险时,应基于最佳GFR估计进行个体化治疗。

局限性

  • 大型数据库可能在人群层面无法检测到mGFR的获益。
  • 需要在这些临床认为mGFR有用的患者亚组中开展研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Of the glomerular, tubular and endocrine functions of the kidney, nephrologists have mostly focused their attention on the glomerular functions-albuminuria and glomerular filtration rate (GFR)-to grade the severity of chronic kidney disease (CKD). Although both albuminuria and GFR are associated with renal and cardiovascular morbidity and mortality, the utility of measured GFR (mGFR) has been questioned. GFR when measured adequately is the most precise measure of glomerular function and can be useful to individualize therapy among patients with CKD. In situations where estimated GFR is known to provide imprecise estimates of glomerular function, for example, sarcopenia and advanced cirrhosis, the measurement of GFR may be especially important. We discuss several clinical situations where mGFR can potentially influence the quality of life or complications of therapy because of interventions based on imperfect knowledge of GFR. We reason that although large databases may not detect the benefits of mGFR at the population level, precision medicine requires that therapy be individualized based on the best estimate of GFR that can be obtained particularly when the risk of harm is increased. The recent standardization of mGFRs is a step in the right direction and may help in treating the individual patient with CKD with a lower risk of complications and a better quality of life. We call for research in these subgroups of patients where it is clinically felt that mGFR is useful for clinical decision-making.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Agarwal R, Delanaye P. Glomerular filtration rate: when to measure and in which patients? Nephrol Dial Transplant. 2019. PMID: 30520986. doi:10.1093/ndt/gfy363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。